| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $501K | +18.2% |
| R&D Expense | $30.9M | +89.8% |
| SG&A Expense | $13.2M | -1.4% |
| Operating Income | -$43.6M | -49.1% |
| Pre-tax Income | -$39.8M | -42.8% |
| Income Tax | $4K | — |
| Net Income | -$39.8M | -40.0% |
| EPS (Basic) | -$0.93 | +66.5% |
| EPS (Diluted) | -$0.93 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.9M | -34.9% |
| Short-term Investments | $41.6M | -33.6% |
| Current Assets | $64.4M | -32.9% |
| Total Assets | $66.9M | -31.5% |
| Current Liabilities | $14.8M | +96.6% |
| Long-term Debt | $0 | — |
| Total Liabilities | $14.8M | +65.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.0M | -34.1% |
| Investing Cash Flow | $23.4M | +140.7% |
| Financing Cash Flow | -$141K | -100.2% |
| +66.5% |
| Stockholders' Equity |
| $52.1M |
| -41.3% |